Dozens of conditions can look like Parkinson’s disease, and telling them apart is harder than most people realize. A 2025 study following patients over ten years found that roughly one in seven initial Parkinson’s diagnoses was later revised, with the rate climbing closer to one in five when dementia with Lewy bodies was counted separately.1PubMed Central. Stability and Accuracy of a Diagnosis of Parkinson Disease Over 10 Years The conditions that create this confusion range from other neurodegenerative diseases to medication side effects, blood-vessel damage in the brain, metabolic disorders, and even brain infections.
Why So Many Conditions Look Like Parkinson’s
Parkinson’s disease sits within a broader category that neurologists call “parkinsonism,” which simply means a movement pattern dominated by slowness of movement, stiffness, and sometimes tremor. These symptoms arise when dopamine-producing neurons in a specific part of the brainstem degenerate. But damage to that same brain region, or to the circuits it feeds, can happen for many different reasons. The underlying pathology in true Parkinson’s involves a protein called alpha-synuclein clumping into structures known as Lewy bodies inside neurons. Other diseases involve different proteins, different brain areas, or no protein clumping at all, yet they produce strikingly similar outward symptoms because the dopamine system still ends up disrupted.2PubMed Central. Parkinson’s disease and parkinsonism: neuropathology
Progressive Supranuclear Palsy
Progressive supranuclear palsy (PSP) is one of the most commonly confused look-alikes. It shares Parkinson’s slowness and rigidity, but it tends to hit balance much earlier and more severely, leading to backward falls within the first year or two. The hallmark that eventually sets PSP apart is difficulty moving the eyes vertically, especially looking downward. This eye-movement problem can make reading, eating, or navigating stairs surprisingly difficult. PSP involves a different culprit protein, tau, rather than the alpha-synuclein seen in Parkinson’s.3PubMed Central. Richardson Syndrome Variant of Progressive Supranuclear Palsy: A Case Report
On brain MRI, PSP often produces a distinctive pattern of midbrain shrinkage that radiologists call the “hummingbird sign” because the brainstem profile resembles a hummingbird in side view.4PubMed Central. Progressive Supranuclear Palsy Unmasked After Post-COVID-19 Functional Decline in an Elderly Patient: A Diagnostic Challenge PSP also responds poorly to levodopa, the standard Parkinson’s medication. In one study comparing medication responses, people with Parkinson’s improved their motor scores by about 29% after a levodopa dose, while those with PSP improved by only about 8%.5PubMed Central. Acute Levodopa Challenge in Atypical Parkinsonism: Comprehensive Analysis of Individual Motor Responses
Multiple System Atrophy
Multiple system atrophy (MSA) is the other major condition driven by alpha-synuclein, the same protein involved in Parkinson’s, but in MSA the protein accumulates inside a different type of brain cell. The result is a disease that can start looking almost identical to Parkinson’s but tends to progress faster and involves more prominent problems with the autonomic nervous system: severe drops in blood pressure on standing, bladder difficulties, and sexual dysfunction that often precede the movement symptoms by years.6PubMed Central. Non-motor symptoms in multiple system atrophy: A comparative study with Parkinson’s disease and progressive supranuclear palsy Some people with MSA also develop cerebellar symptoms like poor coordination and slurred speech, which are unusual in Parkinson’s.2PubMed Central. Parkinson’s disease and parkinsonism: neuropathology
Like PSP, MSA responds much less to levodopa than Parkinson’s does. The same levodopa-challenge study found MSA patients improved by roughly 12%, compared with about 29% in Parkinson’s patients.5PubMed Central. Acute Levodopa Challenge in Atypical Parkinsonism: Comprehensive Analysis of Individual Motor Responses A heavy burden of non-motor symptoms can also be a clue: one study found that over 85% of MSA patients had more than ten distinct non-motor symptoms, far more than the roughly 29% of Parkinson’s patients who hit that threshold.6PubMed Central. Non-motor symptoms in multiple system atrophy: A comparative study with Parkinson’s disease and progressive supranuclear palsy
Corticobasal Degeneration
Corticobasal degeneration (CBD) is rarer and stranger than the other atypical parkinsonisms. It typically starts on one side of the body with stiffness, clumsiness, and sometimes involuntary posturing of a hand or foot. What makes CBD stand out is a constellation of cortical symptoms, meaning problems that suggest the brain’s outer layer is affected, not just the deep movement centers. These include difficulty performing skilled movements even though muscle strength is fine, trouble recognizing objects by touch in the affected hand, and sometimes the unsettling phenomenon of “alien limb,” where one hand seems to act on its own, reaching for objects or interfering with the other hand’s tasks.7Archives of Clinical Neuropsychology. B – 11 Alien Limb and Corticobasal Degeneration: a Neuropsychological Case Study CBD is also a tauopathy, like PSP, and levodopa provides little relief.
Dementia With Lewy Bodies
Dementia with Lewy bodies (DLB) shares the same underlying pathology as Parkinson’s, which makes drawing a clean line between them genuinely difficult. Both involve alpha-synuclein Lewy bodies spreading through the brain, and both can produce slowness, rigidity, and tremor. The clinical convention has been that if cognitive decline appears before or within a year of movement symptoms, the diagnosis is DLB, and if movement symptoms come first with dementia developing later, the diagnosis is Parkinson’s disease dementia. But this timing-based rule is somewhat arbitrary. Some researchers have argued that Parkinson’s disease dementia and DLB are effectively the same disease at different stages, with Lewy body pathology spread throughout the brain in both.8PubMed Central. Parkinson’s Disease and Dementia with Lewy Bodies: One and the Same
What distinguishes DLB in practice is the prominence of visual hallucinations, fluctuating alertness, and extreme sensitivity to antipsychotic medications, all of which tend to appear early. People with DLB may have good days where they seem almost normal and bad days where they are confused and drowsy, a pattern of fluctuation less typical in straightforward Parkinson’s.
Vascular Parkinsonism
When small strokes or chronic blood-vessel disease damages the brain’s deep white matter, the result can look a lot like Parkinson’s. Vascular parkinsonism tends to affect the legs disproportionately, producing a shuffling, magnetic-seeming gait where the feet almost stick to the floor, while the arms and hands are relatively spared. Classic Parkinson’s tremor is typically absent.9PubMed Central. Vascular Parkinsonism: A Review on Management updates An early study defining this pattern found that gait trouble was the first symptom in 90% of these patients, versus only 7% of typical Parkinson’s patients, and that high blood pressure was present in 70% of them.10PubMed. Lower body parkinsonism: evidence for vascular etiology
Vascular parkinsonism tends to progress in a stepwise fashion, sometimes worsening suddenly after a new small stroke and then stabilizing, rather than the slow, steady decline of Parkinson’s. It generally responds poorly to levodopa, and treatment focuses instead on managing the underlying vascular risk factors like blood pressure and cholesterol.
Normal Pressure Hydrocephalus
Normal pressure hydrocephalus (NPH) is worth knowing about because, unlike most Parkinson’s mimics, it is potentially treatable. NPH happens when cerebrospinal fluid accumulates in the brain’s ventricles, gently compressing surrounding tissue. The classic triad involves impaired gait, cognitive decline, and loss of bladder control.11PubMed Central. A Randomized Trial of Shunting for Idiopathic Normal-Pressure Hydrocephalus The gait in NPH can resemble Parkinson’s shuffling walk, and the slowness and cognitive fog overlap enough to cause confusion. A surgical shunt that drains excess fluid can improve symptoms, making this one of the few reversible causes of a Parkinson’s-like picture. The challenge is that NPH mainly affects older adults, the same age group at highest risk for actual Parkinson’s, and the two conditions can even coexist.
Drug-Induced Parkinsonism
Certain medications can produce movement symptoms virtually indistinguishable from Parkinson’s disease. The best-known offenders are older antipsychotic drugs, but the list extends to some anti-nausea medications, the epilepsy drug valproate, the immunosuppressant cyclosporine, and certain herbal supplements. A 2025 review highlighted that drug-induced parkinsonism remains underrecognized and can develop with newer medication classes as well, including drugs used to treat movement disorders themselves.12PubMed Central. Drug-Induced Parkinsonism: A Structured, Mechanism-Informed Approach to Identification and Management
The critical difference is that drug-induced parkinsonism is usually reversible. Most people recover within six to twelve months after the offending medication is stopped, though a minority experience lingering symptoms. Some researchers suspect that in those persistent cases, the drug unmasked early Parkinson’s that was already developing beneath the surface. A careful medication history is one of the simplest and most important steps in evaluating anyone who develops new parkinsonian symptoms.
Essential Tremor
Essential tremor is not really a form of parkinsonism, but it gets confused with Parkinson’s more often than almost any other condition. Both cause shaking, and both become more common with age. The confusion stems from the fact that the two conditions are not as neatly separable as textbooks suggest. Parkinson’s tremor classically happens at rest (hands shaking while sitting still), while essential tremor classically appears during action (hands shaking while holding a cup or writing). In practice, rest tremor sometimes appears in people with longstanding essential tremor, and some Parkinson’s patients have a prominent action tremor. The two diseases can also coexist in the same person.13PubMed Central. Distinguishing essential tremor from Parkinson’s disease: bedside tests and laboratory evaluations
Clinicians look at frequency, pattern, and distribution of the tremor, along with other neurological findings, to tell the two apart. Essential tremor tends to affect both hands symmetrically from the start, often involves the voice or head, and lacks the slowness and stiffness that characterize Parkinson’s. When the clinical picture is ambiguous, brain imaging that evaluates the dopamine system can help, since Parkinson’s shows dopamine loss and essential tremor does not.14PubMed Central. Differentiating Parkinson’s Disease from Essential Tremor Using Transcranial Sonography: A Systematic Review and Meta-Analysis
Wilson’s Disease and Toxic Exposures
Wilson’s disease is a genetic condition in which the body cannot properly excrete copper, leading to toxic copper buildup in the liver and brain. Among its neurological effects, it can produce dystonia and parkinsonism, sometimes closely mimicking Parkinson’s. Wilson’s disease was once thought to appear mainly in children and teenagers, but cases are now recognized across a wide age range, including adults over 70.15PubMed Central. Wilson’s disease and other neurological copper disorders Genetic testing and blood or urine copper levels can confirm the diagnosis, and this matters enormously because Wilson’s disease is treatable with copper-chelating drugs. Missing it means missing one of the few curable causes of parkinsonism.
Chronic manganese exposure produces another Parkinson’s look-alike called manganism. Historically associated with miners and welders, manganism causes slowness, rigidity, and gait problems that overlap heavily with Parkinson’s. The damage occurs through a different pathway than the alpha-synuclein accumulation in Parkinson’s.16PubMed Central. Manganese exposure induces parkinsonism-like symptoms by Serpina3n-TFEB-v/p-ATPase signaling mediated lysosomal dysfunction Unlike Parkinson’s, manganism tends to spare the classic resting tremor and may improve once exposure stops, though permanent damage can occur with prolonged exposure.
Functional Parkinsonism
Functional (sometimes called psychogenic) parkinsonism produces genuine, disabling movement symptoms, but without the progressive brain degeneration seen in Parkinson’s disease. The brain’s hardware is intact; the problem lies in how the nervous system processes and executes movement. This is not malingering or faking. People with functional parkinsonism are often severely impaired, and the symptoms are involuntary.
Several features help clinicians distinguish functional parkinsonism from neurodegenerative disease. The onset tends to be abrupt rather than gradual. Symptoms may fluctuate dramatically, sometimes disappearing when the person is distracted. When testing repetitive finger-tapping, Parkinson’s patients show a characteristic progressive slowing and shrinking of movement, while functional parkinsonism patients often do not. Other clues include bilateral shaking from the very start, exaggerated resistance during passive limb movement without the typical “cogwheel” quality, and a gait pattern that looks unusual but does not match any recognized neurological gait disorder.17PubMed. Psychogenic (functional) parkinsonism The tremor in functional parkinsonism can shift in frequency over time and tends to entrain, meaning it changes to match the rhythm if the person is asked to tap with the other hand.18PubMed Central. Functional (psychogenic) movement disorders – Clinical presentations Dopamine-system imaging appears normal, which can be reassuring for both the clinician and the patient.
Post-Infectious Parkinsonism
The connection between infections and Parkinson’s-like symptoms has a long history. The most famous example is the wave of encephalitis lethargica that followed the 1918 influenza pandemic, leaving survivors with severe, chronic parkinsonian features.19PubMed Central. Infectious Etiologies of Parkinsonism: Pathomechanisms and Clinical Implications A variety of viruses have since been linked to parkinsonism, either by directly damaging dopamine neurons during brain infection or by triggering inflammatory processes that continue after the acute illness resolves. The COVID-19 pandemic renewed interest in this area, as cases of new-onset parkinsonism following SARS-CoV-2 infection began appearing in the literature, though whether the virus directly causes lasting parkinsonism or merely unmasks latent vulnerability remains an open question.20PubMed Central. Viruses, parkinsonism and Parkinson’s disease: the past, present and future
How Doctors Tell These Conditions Apart
The diagnostic process for distinguishing Parkinson’s from its mimics relies on several complementary approaches. The first and most important remains a careful clinical examination. Specific patterns of symptom onset, distribution, and progression carry a great deal of information. Parkinson’s typically starts on one side, includes resting tremor, progresses slowly, and responds well to levodopa. Any major deviation from that profile raises the possibility of something else.
A levodopa trial is itself a diagnostic tool. The fact that Parkinson’s patients improve their motor scores by roughly 29% on levodopa while PSP and MSA patients improve by only about 8% and 12%, respectively, makes medication response clinically useful.5PubMed Central. Acute Levodopa Challenge in Atypical Parkinsonism: Comprehensive Analysis of Individual Motor Responses A poor or absent response does not guarantee an alternative diagnosis, since some Parkinson’s patients have modest initial responses too, but it does warrant a careful second look.
Imaging plays an increasingly important role. A dopamine transporter scan can confirm that dopamine-producing neurons are degenerating, which helps rule out essential tremor, drug-induced parkinsonism, and functional parkinsonism, all of which show a normal scan. Structural MRI can reveal the midbrain atrophy of PSP, the cerebellar changes of MSA, the enlarged ventricles of normal pressure hydrocephalus, or the small-vessel disease pattern of vascular parkinsonism.
Newer biomarker tests are pushing diagnosis in a more biological direction. A technique called seed amplification can detect misfolded alpha-synuclein in spinal fluid, skin biopsies, and even blood samples. A recent systematic review found that across tissue types, these assays achieved about 86% sensitivity and 92% specificity for identifying Parkinson’s and related synucleinopathies.21PubMed Central. Alpha-Synuclein Seed Amplification Assays in Parkinson’s Disease: A Systematic Review and Network Meta-Analysis Even a skin biopsy looking for phosphorylated alpha-synuclein has shown accuracy on par with spinal fluid tests.22JAMA. Skin Biopsy Detection of Phosphorylated α-Synuclein in Patients With Synucleinopathies These tests are not yet routine everywhere, but they are shifting the field away from purely clinical guesswork and toward confirming what is happening at a molecular level.
Non-Motor Symptoms as Diagnostic Clues
When movement symptoms alone are not enough, the pattern of non-motor problems can help point toward the right diagnosis. One study comparing Parkinson’s, MSA, and PSP found that the total burden of non-motor symptoms differed substantially across the three. Fainting episodes, loss of motivation, swallowing difficulties, and loss of sexual interest were more strongly associated with MSA, while concentration and memory problems were more characteristic of Parkinson’s and PSP.6PubMed Central. Non-motor symptoms in multiple system atrophy: A comparative study with Parkinson’s disease and progressive supranuclear palsy In MSA, several non-motor symptoms, including REM sleep behavior disorder and constipation, preceded the onset of movement problems by years. Sleep disorders, by contrast, were more prevalent in Parkinson’s than in the atypical parkinsonisms as a group.23PubMed. Comparative analysis of non-motor symptoms in patients with Parkinson’s Disease and atypical parkinsonisms
Non-motor symptoms are rarely sufficient on their own to make a diagnosis, but they add useful context. If someone has both parkinsonian movement features and prominent early autonomic failure, MSA moves higher on the list. If the movement symptoms coexist with vivid visual hallucinations and dramatic fluctuations in alertness, Lewy body dementia becomes more likely. Clinicians who consider the full clinical picture, not just the tremor or the stiffness, are more likely to arrive at the correct diagnosis sooner.
How Often Parkinson’s Gets Misdiagnosed
The reality of diagnostic accuracy is humbling. The ten-year follow-up study mentioned at the outset found that among practicing neurologists (as opposed to subspecialty movement-disorder centers), about 13% of Parkinson’s diagnoses were eventually revised, most of them within the first two years. When Lewy body dementia reclassifications were included, the figure rose to nearly 18%.1PubMed Central. Stability and Accuracy of a Diagnosis of Parkinson Disease Over 10 Years Even with widespread use of dopamine transporter imaging, clinical uncertainty persisted. Specialized movement-disorder centers report lower misdiagnosis rates, but most patients are not diagnosed at such centers.
This diagnostic instability is not necessarily a sign of medical failure. Many of these conditions genuinely look the same in their early stages, and the features that ultimately distinguish them, like the eye-movement problems of PSP or the cerebellar signs of MSA, may take years to develop. The practical takeaway is that a Parkinson’s diagnosis, especially a recent one, deserves regular re-evaluation. If standard treatment is not working as expected, if symptoms are progressing unusually fast, or if new features appear that do not fit the typical Parkinson’s profile, revisiting the diagnosis is reasonable and worthwhile. It is not an insult to the original doctor; it is just how these diseases work.